Cancer Research Horizons

At booth #58, The Institute of Cancer Research, London, is an independent research institute based across two London sites: one in Chelsea in the heart of the UK capital, and one in Sutton, 30 minutes from Gatwick international airport. A member institution of the University of London, we have an outstanding record of achievement dating back more than 100 years.  Researchers in our Centre for Cancer Drug Discovery, now based in a state-of-the-art, £70m new building in Sutton, have discovered 21 drug candidates since 2005, of which 13 have progressed into clinical trials, in collaboration with industry partners.  Our drug discovery and development pipeline: https://www.icr.ac.uk/working-with-industry/our-therapeutic-pipeline
Website:
icr.ac.uk
Jennifer Hodgson
LinkedIn logo Business Development Manager 

Catalyst Clinical Research

Exhibiting at booth 50 with the UK delegation, Catalyst is a clinical research organisation (CRO)that provides highly customisable solutions to the global biopharmaceutical industry through two established, branded solutions: CatalystOncology and Catalyst Flex. The company provides multi-therapeutic global resourcing and functional services through Catalyst Flex, and full-service oncology CRO offerings through Catalyst Oncology.

With over 800 staff andoffices in the United States and Europe, Catalyst's flexible service model isbuilt from more than a decade of listening to customers, devising customer-centric solutions, and helping customers drive breakthrough clinical studies by leveraging expert teams and innovative technologies.

Amy Nguyen
LinkedIn logo Global Business Development 

CLINICAL ACCELERATOR

Clinical Accelerator is an independent European clinical trial management organisation offering a range of clinical research and patient enrolment support services to worldwide clients in the pharmaceutical, biotechnology and medical device industries.

We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines.

Placing clinical trials in our Eastern European countries of operation allows Clinical Accelerator to achieve significant cost savings for our clients. Fast and large-scale patient recruitment is another important advantage. To ensure excellent quality of our Eastern European trials, we carefully select sites and investigators able to work to the highest quality standards with full ICH GCP compliance.

Clinical Accelerator provides client-tailored services. We are always prepared to adjust our system and procedures to the requirements of virtual, small and medium-sized biotech sponsors or larger pharma companies. We take a proactive role in the management of our projects based on intensive communication with our sponsors and joint commitment to success and always take responsibility for delivering clinical trials to agreed timeframes and within agreed budgets.

We deliver affordable clinical trials solutions with quality and speed!

Anna Nikitina
LinkedIn logo Director of Business Development 

Cognite

Exhibiting at booth 50 with the UK delegation, Cognite is an independent healthcare communications agency with particular expertise in highly specialist, innovative medicines, including rare and ultra-rare diseases.Our mission is to bring science to life. Our expert scientific knowledge, inspiring creativity, insightful strategy and best-in-class client services all combine to rapidly deliver success in line with our clients' brand ambition.

Our core services include strategy, creative and promotional, medical affairs, training and internal engagement, patient care and digital realisation.
Sean Cush
LinkedIn logo Chief Business Officer 
Lee Hurley
LinkedIn logo Chief Executive Officer 
Stephanie Westwood
LinkedIn logo Chief Scientific Officer